Estrogens and Breast Cancer

David Atkins, MD
Arch Intern Med. 1991;151(9):1882. doi:10.1001/archinte.1991.00400090148031.
Text Size: A A A
Published online

To the Editor. —  The recent article by Dupont and Page1 provides a muchneeded review of the studies of estrogens and breast cancer. However, meta-analysis of epidemiologic research faces different problems from those faced by the analysis of data from clinical trials. Evaluating the methods of observational studies, to decide which results to include, presents the first obstacle. Random assignment, placebo control subjects, and blinded assessment have become standard elements of a well-conducted clinical trial. In contrast, there is less agreement over what constitutes acceptable methods in epidemiologic research.2 The authors chose to exclude few studies, despite substantial differences among the studies in the selection of subjects and control subjects, the definitions of exposure, and the control of potential confounders. The amount and the direction of bias introduced by these differences is controversial. The authors found no "obvious" connection between methodology and risk estimates. However, bias in individual


Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.